Neurodegenerative disorders
References
Background information
1. Alzheimer Europe (2010). Alzheimer’s disease. Available at http://www.alzheimer-europe.org/EN/Dementia/Alzheimer-s-disease
2. Alzheimer Europe (2009). Who is affected by Alzheimer’s disease? Available at http://www.alzheimer-europe.org/index.php/Dementia/Alzheimer-s-disease/Who-is-affected-by-Alzheimer-s-disease
3. Alzheimer Europe (2010). The impact of Alzheimer’s disease in Europe. Available at http://www.alzheimer-europe.org/EN/Research/PharmaCog/Why-Pharmacog/(language)/eng-GB
4. European Parkinson’s Disease Association (2011). EPDA Annual report 2010-2011. Available at http://www.epda.eu.com/welcome/
5. European Parkinson’s Disease Association (2011). Life with Parkinson’s. Available at http://www.epda.eu.com/welcome/
Physiologic age-related cognitive decline
6. Singh-Manoux A et al (2011). Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ; 343:d7622 doi: 10.1136/bmj.d7622
7. Swift CG & Tiplady B (1988). The effects of age on the response to caffeine. Psychopharmacology (Berl);94:29-31.
8. Rees K et al (1999). The influences of age and caffeine on psychomotor and cognitive function. Psychopharmacology (Berl);145:181-188.
9. Hogervorst E et al (1998). Caffeine improves memory performance during distraction in middle-aged, but not in young or old subjects. Hum Psychopharmacol;13:277-284.
10. Lorist MM et al (1995). Aging, caffeine, and information processing: an event-related potential analysis. Electroencephalogr Clin Neurophysiol;96:453-467.
11. Jarvis MJ (1993). Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology;110:45-52.
12. Hameleers PA et al (2000). Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups. Hum Psychopharmacol;15:573-581.
13. van Hooren SA et al (2005). Influence of cognitive functioning on functional status in an older population: 3- and 6-year follow-up of the Maastricht Aging Study. Int J Geriatr Psychiatry;20:883-888.
14. Cropley V et al (2011). Does coffee enriched with chlorogenic acids improve mood and cognition after acute administration in healthy elderly? A pilot study. Psychopharmacology (Berl); 219(3):737-49.
15. Santos C et al (2010). Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis;20 Suppl 1:S187-204.
16. Johnson-Kozlow M et al (2002). Coffee consumption and cognitive function among older adults. Am J Epidemiol;156:842-850.
17. Ritchie K et al (2007). The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology;69:536-545.
18. Arab L et al (2011). Gender Differences in Tea, Coffee, and Cognitive Decline in the Elderly: The Cardiovascular Health Study. J Alzheimers Dis. Aug 12. [Epub ahead of print]
19. van Gelder BM et al (2007). Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study. Eur J Clin Nutr;61:226-32.
20. Wu MS et al (2011). Socio-demographic and health-related factors associated with cognitive impairment in the elderly in Taiwan. BMC Public Health;11:22.
Alzheimer’s disease
21. Barranco Quintana JL et al (2007). Alzheimer’s disease and coffee: a quantitative review. Neurol Res;29:91-5
22. Maia L & de Mendonça A (2002). Does caffeine intake protect from Alzheimer’s disease? Eur J Neurol;9:377-82.
23. Lindsay J et al (2002). Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol;156:445-53.
24. Eskelinen MH et al (2009). Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis;16:85-91.
25. Laitala VS et al (2009). Coffee drinking in middle age is not associated with cognitive performance in old age. Am J Clin Nutr;90:640-6.
26. Gelber RP et al (2011). Coffee intake in midlife and risk of dementia and its neuropathologic correlates. J Alzheimers Dis;23:607-15.
27. Arendash GW et al (2006). Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production. Neuroscience;142:941-52.
28. Arendash GW et al (2009). Caffeine reverses cognitive impairment and decreases brain amyloid-β levels in aged Alzheimer’s disease mice. J Alzheimers Dis;17:661-80.
29. Cao C et al (2009). Caffeine suppresses amyloid-β levels in plasma and brain of Alzheimer’s disease transgenic mice. J Alzheimers Dis;17:681-97.
30. Cao C et al (2011). Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer’s mice. J Alzheimers Dis; 25(2):323-35.
31. Han ME et al (2009). Regulation of cerebrospinal fluid production by caffeine consumption. BMC Neurosci;10:110.
32. Wostyn P et al (2011). Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine’s Protective Effect against Alzheimer’s Disease. Int J Alzheimers Dis;2011:617420.
33. Tohda C et al (2005). Search for natural products related to regeneration of the neuronal network. Neurosignals;14:34-45.
34. Tohda C et al (1999). Trigonelline-induced neurite outgrowth in human neuroblastoma SK-N-SH cells. Biol Pharm Bull;22:679-82.
35. Kim HS et al (2004). Inhibitory effects of long-term administration of ferulic acid on microglial activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice. Biol Pharm Bull;27:120-1.
36. Cho JY et al (2005). Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice. Prog Neuropsychopharmacol Biol Psychiatry;29:901-7.
Parkinson’s disease
37. Nefzger MD et al (1968). A retrospective study of smoking in Parkinson’s disease. Am J Epidemiol; 88:149-158.
38. Jimenez-Jimenez FJ et al (1992). Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson’s disease: a case-control study. Mov Disord; 7:339-44.
39. Fall PA et al (1999). Nutritional and occupational factors influencing the risk of Parkinson’s disease: a case-control study in southeastern Sweden. Mov Disord; 14:28-37.
40. Hellenbrand W et al (1996). Diet and Parkinson’s disease. I. A possible role for the past intake of specific foods. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology;47:636-43.
41. Ross GW et al (2000). Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA; 283:2674-2679.
42. Hernan MA et al (2002). A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease. Ann Neurol;52:276-84.
43. Costa J et al (2010). Caffeine exposure and the risk of Parkinson’s disease: a systematic review and meta-analysis of observational studies. J Alzheimers Dis;20 Suppl 1:S221-38.
44. Ascherio A et al (2001). Prospective study of caffeine consumption and risk of Parkinson’s disease in men and women. Ann Neurol;50:56-63.
45. Ascherio A et al (2003). Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease. Neurology;60:790-5.
46. Kuwana Y et al (1999). Antiparkinsonian activity of adenosine A2A antagonists in experimental models. Adv Neurol, 80:121-3.
47. Fenu S & Morelli M (1998). Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors. Eur J Neurosci;10:1878-84.
48. Chen JF et al (2001). Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson’s disease. J Neurosci;21:RC143.
49. Morelli M et al (2009). Adenosine A2A receptors and Parkinson’s disease. Handb Exp Pharmacol;193:589-615.
50. Iida M et al (1999). Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res; 838:51-9.
Stroke
51. Larsson SC et al (2008). Coffee and tea consumption and risk of stroke subtypes in male smokers. Stroke;39:1681-7.
52. Larsson SC et al (2011). Coffee consumption and risk of stroke in women. Stroke;42:908-12.
53. Lopez-Garcia E et al (2009). Coffee consumption and risk of stroke in women. Circulation;119:1116-23.
54. Larsson SC & Orsini N (2011). Coffee consumption and risk of stroke: A dose-response meta-analysis of prospective studies. Am J Epidemiol; Sep 13. [Epub ahead of print]
